These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Pool M; Kol A; de Jong S; de Vries EGE; Lub-de Hooge MN; Terwisscha van Scheltinga AGT MAbs; 2017; 9(8):1370-1378. PubMed ID: 28873009 [TBL] [Abstract][Full Text] [Related]
43. Mutual inhibition of cobalamin and siderophore uptake systems suggests their competition for TonB function. Kadner RJ; Heller KJ J Bacteriol; 1995 Sep; 177(17):4829-35. PubMed ID: 7665457 [TBL] [Abstract][Full Text] [Related]
44. 99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation. Xia X; Feng H; Li C; Qin C; Song Y; Zhang Y; Lan X Nucl Med Biol; 2016 Jan; 43(1):89-96. PubMed ID: 26466867 [TBL] [Abstract][Full Text] [Related]
45. Positron Emission Tomography Imaging of Platelet-Derived Growth Factor Receptor β in Colorectal Tumor Xenograft Using Zirconium-89 Labeled Dimeric Affibody Molecule. Cai H; Shi Q; Tang Y; Chen L; Chen Y; Tao Z; Yang H; Xie F; Wu X; Liu N; Yang Y; Wu H; Tian R; Lu X; Li L Mol Pharm; 2019 May; 16(5):1950-1957. PubMed ID: 30986347 [TBL] [Abstract][Full Text] [Related]
46. PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors. Hoeben BA; Kaanders JH; Franssen GM; Troost EG; Rijken PF; Oosterwijk E; van Dongen GA; Oyen WJ; Boerman OC; Bussink J J Nucl Med; 2010 Jul; 51(7):1076-83. PubMed ID: 20554724 [TBL] [Abstract][Full Text] [Related]
47. A radiopharmaceutical [ Tang Y; Hu Y; Liu W; Chen L; Zhao Y; Ma H; Yang J; Yang Y; Liao J; Cai J; Chen Y; Liu N Nucl Med Biol; 2019 Mar; 70():23-31. PubMed ID: 30826708 [TBL] [Abstract][Full Text] [Related]
48. PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles. Pérez-Medina C; Tang J; Abdel-Atti D; Hogstad B; Merad M; Fisher EA; Fayad ZA; Lewis JS; Mulder WJ; Reiner T J Nucl Med; 2015 Aug; 56(8):1272-7. PubMed ID: 26112022 [TBL] [Abstract][Full Text] [Related]
49. Immuno-PET Imaging to Assess Target Engagement: Experience from Menke-van der Houven van Oordt CW; McGeoch A; Bergstrom M; McSherry I; Smith DA; Cleveland M; Al-Azzam W; Chen L; Verheul H; Hoekstra OS; Vugts DJ; Freedman I; Huisman M; Matheny C; van Dongen G; Zhang S J Nucl Med; 2019 Jul; 60(7):902-909. PubMed ID: 30733323 [TBL] [Abstract][Full Text] [Related]
50. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody. Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560 [TBL] [Abstract][Full Text] [Related]
51. Absorption and retention of free and milk protein-bound cyano- and hydroxocobalamins. An experimental study in rats. Kornerup LS; Juul CB; Fedosov SN; Heegaard CW; Greibe E; Nexo E Biochimie; 2016 Jul; 126():57-62. PubMed ID: 26626348 [TBL] [Abstract][Full Text] [Related]
52. Yang H; Jenni S; Colovic M; Merkens H; Poleschuk C; Rodrigo I; Miao Q; Johnson BF; Rishel MJ; Sossi V; Webster JM; Bénard F; Schaffer P J Nucl Med; 2017 Mar; 58(3):367-373. PubMed ID: 27789715 [TBL] [Abstract][Full Text] [Related]
53. A patient with the inability to maintain in vivo levels of bound cobalamin (Cbl) and manifestations of tissue deficiency of Cbl. Begley JA; Burkart PT; Hall CA Am J Hematol; 1986 May; 22(1):69-78. PubMed ID: 3953567 [TBL] [Abstract][Full Text] [Related]
54. The metabolism of cobalamin bound to transcobalamin II and to glycoproteins that bind Cbl in HepG2 cells (human hepatoma). Hall CA; Green-Colligan PD; Begley JA J Cell Physiol; 1985 Sep; 124(3):507-15. PubMed ID: 2995422 [TBL] [Abstract][Full Text] [Related]
55. Preclinical Evaluation of the Hsp70 Peptide Tracer TPP-PEG Stangl S; Tei L; De Rose F; Reder S; Martinelli J; Sievert W; Shevtsov M; Öllinger R; Rad R; Schwaiger M; D'Alessandria C; Multhoff G Cancer Res; 2018 Nov; 78(21):6268-6281. PubMed ID: 30228173 [TBL] [Abstract][Full Text] [Related]
56. Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767 [TBL] [Abstract][Full Text] [Related]
57. Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab. Jagoda EM; Vasalatiy O; Basuli F; Opina ACL; Williams MR; Wong K; Lane KC; Adler S; Ton AT; Szajek LP; Xu B; Butcher D; Edmondson EF; Swenson RE; Greiner J; Gulley J; Eary J; Choyke PL Mol Imaging; 2019; 18():1536012119829986. PubMed ID: 31044647 [TBL] [Abstract][Full Text] [Related]
58. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer. Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207 [TBL] [Abstract][Full Text] [Related]
59. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII. Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146 [TBL] [Abstract][Full Text] [Related]
60. Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative. Sah BR; Schibli R; Waibel R; von Boehmer L; Bläuenstein P; Nexo E; Johayem A; Fischer E; Müller E; Soyka JD; Knuth AK; Haerle SK; Schubiger PA; Schaefer NG; Burger IA J Nucl Med; 2014 Jan; 55(1):43-9. PubMed ID: 24337606 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]